Through pathway expression verification, we confirmed that the FTH1 m6A methylation regulatory pathway (CACNA1G-AS1/IGF2BP1) was obviously increased in ovarian cancer samples, and its expression was closely related to tumor malignancy. Here, IGF2BP1 is linked to neoplasm.